Comments on: AstraZeneca and Daiichi Sankyo enter $6bn collaboration as pharma bets big on antibody-drug conjugates

Comments on: AstraZeneca and Daiichi Sankyo enter $6bn collaboration as pharma bets big on antibody-drug conjugates /analyst-comment/astrazeneca-daiichi-sankyo-6bn-collaboration/ The leading site for news and procurement in the pharmaceutical industry Sun, 31 Oct 2021 14:25:05 +0000 hourly 1 https://wordpress.org/?v=6.8.2